Correlation Between Aquestive Therapeutics and Taro Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Taro Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Taro Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Taro Pharmaceutical Industries, you can compare the effects of market volatilities on Aquestive Therapeutics and Taro Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Taro Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Taro Pharmaceutical.

Diversification Opportunities for Aquestive Therapeutics and Taro Pharmaceutical

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Aquestive and Taro is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Taro Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taro Pharmaceutical and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Taro Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taro Pharmaceutical has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Taro Pharmaceutical go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Taro Pharmaceutical

If you would invest  4,297  in Taro Pharmaceutical Industries on August 31, 2024 and sell it today you would earn a total of  0.00  from holding Taro Pharmaceutical Industries or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Aquestive Therapeutics  vs.  Taro Pharmaceutical Industries

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Aquestive Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Taro Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Taro Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Taro Pharmaceutical is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Aquestive Therapeutics and Taro Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and Taro Pharmaceutical

The main advantage of trading using opposite Aquestive Therapeutics and Taro Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Taro Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taro Pharmaceutical will offset losses from the drop in Taro Pharmaceutical's long position.
The idea behind Aquestive Therapeutics and Taro Pharmaceutical Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA